Received Jul 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 5H95B | — |
Wrong vaccine administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. On 21-APR-2025, the patient received the 3rd dose of Kinrix. On an unknown date, the patient did not receive Pediarix. On 21-APR-2025, an unknown time after receiving Kinrix and not applicable after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: Wrong vaccine administration). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 25-JUN-2025 On 25th June 2025, a registered nurse called to report the administration of a Kinrix shot to a 3 year and 9-month-old male patient instead of Pediarix in the DTaP immunization series which led to wrong vaccine administration. The vaccine was administered on 21st April 2025 and was for the third dose. She called to know how to proceed, do they need to revaccinate and make a Safety report?